EDWARDS LIFESCIENCES/ US28176E1082 /
9/23/2024 10:08:52 AM | Chg. +0.800 | Volume | Bid1:30:00 PM | Ask1:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
60.460EUR | +1.34% | 67 Turnover: 4,050.820 |
59.870Bid Size: 300 | 60.410Ask Size: 200 | 36.06 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 2.31 USD | -6.10% |
EPS Diluted: | 2.30 USD | -5.74% |
Revenues per Share: | 9.99 USD | 12.86% |
Book Value per Share: | 11.17 USD | 17.07% |
Cash Flow per Share: | 1.49 USD | -25.61% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 6,004.80 USD | 11.56% |
Net Income: | 1,402.40 USD | -7.85% |
Operating Cash Flow: | 895.80 USD | - |
Cash and Cash Equivalents: | 1,144.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 28.93 | 33.01 |
P/S Ratio: | 6.69 | 7.64 |
P/BV ratio: | 5.98 | 6.82 |
P/CF Ratio: | 44.86 | 51.18 |
PEG: | -4.74 | -5.41 |
Earnings Yield: | 3.46% | 3.03% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 36.06 bill. EUR | 41.53 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 602.4 mill. |
Profitability
Gross Profit Margin: | 77.02% |
EBIT Margin: | 25.55% |
Net Profit Margin: | 23.35% |
Return on Equity: | 20.87% |
Return on Assets: | 14.98% |
Financial Strength
Liquidity I / Cash Ratio: | 95.70% |
Liquidity II / Quick Ratio: | 160.54% |
Liquidity III / Current Ratio: | 337.60% |
Debt / Equity Ratio: | 39.35% |
Dynam. Debt / Equity Ratio: | 295.13% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |